🌱 KidneyEnergy.com

← brief for 2026-11-15 · Slowing decline

Efficacy of SGLT2 Inhibitors in Reducing Cardiovascular Events in Adults with Chronic Kidney Disease, with or without Diabetes: A Systematic Review of Randomized Controlled Trials

Article No results yet Not peer reviewed

Key takeaways

This is a registration for a planned systematic review. It will look at SGLT2 drugs in people with kidney disease. The review is starting, and there are no results yet.

Who did this work

Anna Luisa De Lima Pinto · Victor Barcella

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-14
https://doi.org/10.17605/osf.io/kyb5j